"KB Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences.
| Descriptor ID |
D007624
|
| MeSH Number(s) |
A11.251.210.190.400.500 A11.251.860.180.400.500 A11.436.340.500
|
| Concept/Terms |
KB Cells- KB Cells
- Cell, KB
- Cells, KB
- KB Cell
- HeLa-KB Cells
- Cell, HeLa-KB
- Cells, HeLa-KB
- HeLa KB Cells
- HeLa-KB Cell
|
Below are MeSH descriptors whose meaning is more general than "KB Cells".
Below are MeSH descriptors whose meaning is more specific than "KB Cells".
This graph shows the total number of publications written about "KB Cells" by people in this website by year, and whether "KB Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "KB Cells" by people in Profiles.
-
Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1a. Eur J Pharmacol. 2012 Sep 15; 691(1-3):28-37.
-
Amphiphilic diarylethene as a photoswitchable probe for imaging living cells. J Am Chem Soc. 2008 Nov 26; 130(47):15750-1.
-
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release. 2006 Sep 12; 114(3):277-87.
-
Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells. Int J Cancer. 1995 May 04; 61(3):402-8.
-
Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance. Int J Cancer. 1994 Jul 01; 58(1):85-94.
-
Keratinocyte transglutaminase expression varies in squamous cell carcinomas. J Invest Dermatol. 1994 Apr; 102(4):462-9.
-
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties. Cancer Res. 1994 Mar 15; 54(6):1479-84.
-
Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987 Jan; 84(1):265-9.